Related Experiment Videos
Neurofibrosarcomas of the upper extremity
1Section of Orthopaedic Surgery, University of Michigan Hospitals, Ann Arbor 48109-0328.
The Journal of Hand Surgery
|September 1, 1991
Summary
Neurofibrosarcoma, a rare cancer linked to von Recklinghausen's disease, has a poor prognosis. Early diagnosis and radical surgery are crucial for improving survival rates in patients with this upper extremity malignancy.
Area of Science:
- Oncology
- Surgical Pathology
- Genetics
Background:
- Neurofibrosarcoma is a rare malignancy arising from nerve sheath cells.
- Patients with von Recklinghausen's disease have an increased risk of developing neurofibrosarcoma.
- Malignant tumors of the hand and upper extremity are uncommon, posing diagnostic and therapeutic challenges.
Purpose of the Study:
- To review cases of neurofibrosarcoma involving the upper extremity.
- To analyze clinical presentation, treatment, and outcomes for this rare cancer.
- To identify prognostic factors for neurofibrosarcoma of the upper extremity.
Main Methods:
- Retrospective review of biopsy-proven neurofibrosarcoma cases.
- Data collection from 1950 to 1987 at the University of Michigan.
- Analysis of patient demographics, clinical history, treatment modalities, and survival data.
Main Results:
- Six cases of upper extremity neurofibrosarcoma were identified in patients with von Recklinghausen's disease.
- Average age at presentation was 37 years, with a median age range of 15 to 63 years.
- Five out of six patients died of metastatic disease within an average of 3 years; one patient survived 18 years post-amputation despite recurrence.
Conclusions:
- Neurofibrosarcoma of the upper extremity is a highly lethal cancer with a poor prognosis.
- Early diagnosis and aggressive surgical management, including amputation, offer the best chance for long-term survival.
- Close monitoring and prompt treatment are essential for patients with von Recklinghausen's disease and suspected neurofibrosarcoma.